Integrated Advisors Network’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Integrated Advisors Network's XBI Position: Q1 2026 in Review
Integrated Advisors Network reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 14% in Q1 2026, selling an estimated $60.9K and leaving 2,883 shares worth $368K. The position accounts for 0.02% of the portfolio, ranked #518.
Integrated Advisors Network first reported a position in XBI in Q4 2020 and has held it in 13 quarters since. The position peaked at $664K in Q1 2024. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Integrated Advisors Network held 2,883 shares of State Street SPDR S&P Biotech ETF worth $368K as of Q1 2026.
- Integrated Advisors Network sold 488 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $60.9K.
- State Street SPDR S&P Biotech ETF made up 0.02% of Integrated Advisors Network's portfolio in Q1 2026, its #518 holding.
- Integrated Advisors Network first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 13 quarters since.
- Integrated Advisors Network's State Street SPDR S&P Biotech ETF position peaked at $664K in Q1 2024.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.